Biogen Idec has committed $10 million to support a new consortium including researchers at several academic institutions, with the goal of identifying potential drugs to treat ALS, also known as Lou Gehrig's disease.
http://www.bizjournals.com/boston/blog/bioflash/2012/12/biogen-commits-10m-to-new-als.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_37+%28Physician+Practices+Industry+News%29
http://www.bizjournals.com/boston/blog/bioflash/2012/12/biogen-commits-10m-to-new-als.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_37+%28Physician+Practices+Industry+News%29
No comments:
Post a Comment